Mark A. Applebaum

2.4k citations

44 papers · 1.6k indexed · 1 hit paper · h-index 18

Impact in

Neurology top 1%
- Neuroblastoma Research and Treatments
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism

Papers in

Neurology 29
- Neuroblastoma Research and Treatments 29
Cancer Research 16
- Cancer, Hypoxia, and Metabolism 13

Co-authors: Susan L. Cohn Katherine K. Matthay Samuel L. Volchenboum Navin Pinto Wendy B. London Julie R. Park Andrew D.J. Pearson Gudrun Schleiermacher
Journals: Pediatric Blood & Cancer (6 papers)Journal of Clinical Oncology (5 papers)Cancer (2 papers)Psychology of Addictive Behaviors (2 papers)Oncotarget (2 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Mark A. Applebaum

43 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Advances in Risk Classification and Treatment Strategies for Neuroblastoma 2015 · 611 citations

Peers

Countries citing papers authored by Mark A. Applebaum

Since Specialization

Citations

This map shows the geographic impact of Mark A. Applebaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Applebaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Applebaum more than expected).

Fields of papers citing papers by Mark A. Applebaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Applebaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Applebaum. The network helps show where Mark A. Applebaum may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark A. Applebaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Applebaum Line = papers co-authored together Mark A. Applebaum links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures Cancer Research Communications ·A. S. Sajith, Martín Calveira, Muhammad hardiman Nur Ramadhan, Alexandre Chlenski, Tong Wu, Sang Mee Lee, Ami V. Desai, Chuan He, Susan L. Cohn, Mark A. Applebaum	2024	2
2	5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma JCO Precision Oncology ·Mohansrinivas Chennakesavalu, Muhammad hardiman Nur Ramadhan, May M. Atyia, عباس میرزاد, 隆夫佐川, 王舒娜, Ruitu Lyu, Alexandre Chlenski, Chuan He, Andrea Piunti, Mark A. Applebaum	2024	7
3	Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity Proceedings of the National Academy of Sciences ·Yan‐Hong Cui, Jiangbo Wei, Hao Fan, Wenlong Li, Keira Truong, Emma Wilkinson, M.F. Afzali, Lishi Xie, Zhongyu Zou, Seungwon Yang, Mark A. Applebaum, Justin Kline, Jing Chen, Chuan He, Yu‐Ying He	2024	2
4	Methyltransferase Inhibition Enables Tgfβ Driven Induction of CDKN2A and B in Cancer Cells Molecular and Cellular Biology ·Yen‐Ting Liu, Wakana Ebisu, Xue Xiao, Lei Guo, Xiaoyun Zhou, Mark A. Applebaum, Lin Xu, Stephen X. Skapek	2023	1
5	Adrenergic and mesenchymal signatures are identifiable in cell‐free DNA and correlate with metastatic disease burden in children with neuroblastoma Pediatric Blood & Cancer ·Martín Calveira, Jonas Valani Stein, Muhammad hardiman Nur Ramadhan, Mohansrinivas Chennakesavalu, 隆夫佐川, May M. Atyia, Alexandre Chlenski, Chuan He, Susan L. Cohn, Mark A. Applebaum	2023	6
6	Persistence of racial and ethnic disparities in risk and survival for patients with neuroblastoma over two decades SHILAP Revista de lepidopterología ·Mohansrinivas Chennakesavalu, Colin Yip, Mark A. Applebaum, Sang Mee Lee, Yan Che, Arlene Naranjo, Julie R. Park, Samuel L. Volchenboum, Tara O. Henderson, Susan L. Cohn, Ami V. Desai	2023	2
7	Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group JCO Clinical Cancer Informatics ·Anoop Mayampurath, Siddhi Ramesh, A. Dinham, В.А. Борисов, Mehmet Güllü, Meaghan Granger, Arlene Naranjo, Susan L. Cohn, Samuel L. Volchenboum, Mark A. Applebaum	2021	8
8	Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma JAMA Network Open ·Xiaojuan Wang, Sang Mee Lee, Ami V. Desai, Samuel L. Volchenboum, Arlene Naranjo, Julie R. Park, Wendy B. London, Susan L. Cohn, Mark A. Applebaum	2021	3
9	Nervous system: Embryonal tumors: Neuroblastoma Atlas of Genetics and Cytogenetics in Oncology and Haematology ·Colin Yip, Xiaojuan Wang, Mark A. Applebaum	2020	22
10	Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma Molecular Cancer Therapeutics ·Alexandre Chlenski, Chanyoung Park, 克敏若林, Helen R. Salwen, Brian Budke, D. Pham, R J Miller, Mark A. Applebaum, Emma Wilkinson, Yusuke Nakamura, Philip P. Connell, Susan L. Cohn	2019	20
11	5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma Clinical Cancer Research ·Mark A. Applebaum, Olek Robert Antoni, Jason Karpus, Diana C. West-Szymanski, Meritxell Oliva, Elizabeth Sokol, 宮崎三弘, Zhou Zhang, Wei Zhang, Alexandre Chlenski, Helen R. Salwen, Emma Wilkinson, 克敏若林, Robert L. Grossman, Lucy A. Godley, Barbara E. Stranger, Chuan He, Susan L. Cohn	2019	23
12	Second primary rhabdomyosarcoma of the uterine cervix presenting with synchronous ovarian Sertoli-Leydig cell tumor: An illustrative case of DICER1 syndrome Gynecologic Oncology Reports ·Matthew Cowan, Peter Fritzsche, Andrea D. Olivas, K. Yamamoto, Mark A. Applebaum, Ricardo R. Lastra, S. Diane Yamada	2018	10
13	Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project European Journal of Cancer ·Mark A. Applebaum, Zalman Vaksman, Sang Mee Lee, Eric A. Hungate, Tara O. Henderson, Wendy B. London, Navin Pinto, Samuel L. Volchenboum, Julie R. Park, Arlene Naranjo, Barbara Hero, Andrew D.J. Pearson, Barbara E. Stranger, Susan L. Cohn, Sharon J. Diskin	2016	58
14	Advances in Risk Classification and Treatment Strategies for Neuroblastoma Journal of Clinical Oncology ·Navin Pinto, Mark A. Applebaum, Samuel L. Volchenboum, Katherine K. Matthay, Wendy B. London, Peter F. Ambros, Akira Nakagawara, Frank Berthold, Gudrun Schleiermacher, Julie R. Park, Dominique Valteau‐Couanet, Andrew D.J. Pearson, Susan L. Cohn Hit paper breakdown →	2015	611
15	Comparative Evaluation of Strategies for Quantifying Signaling Pathway Proteins in Ewing Sarcoma Applied immunohistochemistry & molecular morphology ·Mark A. Applebaum, Dafydd G. Thomas, Todd Hembrough, Jon Burrows, Andrew Horvai, Elizabeth R. Lawlor, Steven G. DuBois	2014	1
16	Radiation-induced apoptosis varies among individuals and is modified by sex and age International Journal of Radiation Biology ·Mark A. Applebaum, Andrew D. Skol, Elisabeth E. Bond, Michael Overholtzer, Gareth L. Bond, Kenan Onel	2014	6
17	Perception of transition readiness and preferences for use of technology in transition programs: teens’ ideas for the future International Journal of Adolescent Medicine and Health ·Mark A. Applebaum, Erica Lawson, Emily von Scheven	2013	39
18	Clinical features and outcomes in patients with secondary Ewing sarcoma Pediatric Blood & Cancer ·Mark A. Applebaum, Robert E. Goldsby, John Neuhaus, Steven G. DuBois	2012	20
19	Self-management skills in adolescents with chronic rheumatic disease: A cross-sectional survey Pediatric Rheumatology ·Erica Lawson, Aimee O. Hersh, Mark A. Applebaum, Edward H. Yelin, Megumi J. Okumura, Emily von Scheven	2011	48
20	Clinical features and outcomes in patients with extraskeletal ewing sarcoma Cancer ·Mark A. Applebaum, Jennifer Worch, Katherine K. Matthay, Robert E. Goldsby, John Neuhaus, Daniel C. West, Steven G. DuBois	2011	189

About Mark A. Applebaum

Mark A. Applebaum is a scholar working on Neurology, Cancer Research, Genetics, Speech and Hearing and Molecular Biology, having authored 44 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (29 papers), Cancer, Hypoxia, and Metabolism (13 papers), Cancer therapeutics and mechanisms (7 papers), Glioma Diagnosis and Treatment (6 papers), Sarcoma Diagnosis and Treatment (6 papers), Epigenetics and DNA Methylation (5 papers), Lung Cancer Research Studies (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Neurology (950 citations), Cancer Research (477 citations), Genetics (129 citations), Speech and Hearing (67 citations) and Pulmonary and Respiratory Medicine (317 citations). Mark A. Applebaum has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Susan L. Cohn, Katherine K. Matthay, Samuel L. Volchenboum, Navin Pinto, Wendy B. London, Julie R. Park, Andrew D.J. Pearson, Gudrun Schleiermacher, Dominique Valteau‐Couanet and Peter F. Ambros. Their work appears in journals such as Pediatric Blood & Cancer, Journal of Clinical Oncology, Cancer, Psychology of Addictive Behaviors and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact